JATT II Acquisition

JATT II Acquisition Corp is a blank check company, structured as a special purpose acquisition company and incorporated as a Cayman Islands exempted company. It serves the primary purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company particularly targets, though not exclusively, businesses in biotechnology and life sciences sectors that apply data-driven approaches, such as machine learning, computational biology, structure-based drug design, and related technologies to enhance therapeutic discovery and development processes. Sponsored by JATT Ventures II L.P., it is led by Chief Executive Officer and Chairman Dr. Someit Sidhu, along with Chief Financial Officer Nicholas Fernandez. Headquartered in Westfield, New Jersey and founded in 2026, JATT II Acquisition Corp plays a key role in the financial markets by providing a vehicle for private companies in innovative biotech fields to access public capital markets through de-SPAC transactions.